Lipoatrophy – Friday Pop Quiz 5/20/2022
Which of the following cosmetic injectables is FDA-approved for the treatment of lipoatrophy?
A. Calcium Hydroxyapatite (Radiesse)
B. Silicone
C. Botulinum toxin
D. Poly-L-lactic acid (Sculptra)
E. Deoxycholic acid
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
…
Which of the following cosmetic injectables is FDA-approved for the treatment of lipoatrophy?
A. Calcium Hydroxyapatite (Radiesse)
B. Silicone
C. Botulinum toxin
D. Poly-L-lactic acid (Sculptra)
E. Deoxycholic acid
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
TODAY.com recently posted an article about one woman's experience with subungual melanoma, which was initially diagnosed as a mole. What are some common mimics to nail melanoma that could result in a missed diagnosis, and when should a dermatologist perform a nail biopsy?
For expert advice, I reached out to Shari Lipner, MD, PhD, associate professor of clinical dermatology and director of t … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Harold S. Rabinovitz (Professor of Dermatology at Medical College of Georgia) about the latest trends in managing facial melanoma. Watch as he unveils how doctors are better equipped to diagnose patients using new devices, plus the single treatment option he considers a game changer.
… 
A 55-year-old male is admitted to the hospital with the condition depicted in the image. He admits trauma to the region, and states it started out as papules and pustules with surrounding erythema and tenderness. Which of the following monoclonal gammopathies may be associated with this condition?
A. IgE
B. IgA
C. IgM
D. IgG
E. IgD
To find out the correct answer and read the ex … 
While we have an increasing armamentarium of biologic agents and targeted systemic medications for certain dermatologic conditions such as psoriasis or atopic dermatitis, treatment options are still limited for a litany of other inflammatory cutaneous disorders. Additionally, when discussing therapeutic options, patients often opt for medications that are established, safe, well-tolerated and mini … 